IL6 and neoplasm: TAMs express tumor necrosis factor (TNF)-α and interleukin (IL)-6, which ultimately induce the development of epithelial-mesenchymal transition (EMT) 27 to play a pro-tumor inflammatory action, promote the formation of blood vessels and lymphatics, promote the growth and metastasis of tumors, and suppress the immune response 27-28.